"How long does it take" has at least four honest answers, because the trials measured four different things and they do not move on the same clock: the creatine inside the muscle, the number on the scale, performance in repeated hard efforts, and strength or muscle over a training block. This page puts each one on a timeline with the study that measured it. It reports what trials administered and found; it is research journalism, not usage guidance, per our editorial standards.
The timeline, by what was measured
| When | What moved | Intake studied | Study (subjects) |
|---|---|---|---|
| Day 2 | Muscle uptake at its fastest; 32% of the dose retained | 5 g × 6 a day | Harris 1992 (17) |
| Day 5 | Peak torque higher across repeated maximal bouts | 5 g × 4 a day | Greenhaff 1993 (12) |
| Day 5–6 | Muscle total creatine ~+20%, near plateau | 20 g/day | Hultman 1996 (31); Greenhaff 1994 (8) |
| Day 7 | Body mass +0.75 kg on average (not significant) | 25 g/day | Powers 2003 (32) |
| Day 28 | Muscle total creatine ~+20% without loading | 3 g/day | Hultman 1996 (31) |
| Day 28 | Body mass significantly higher; total body water up | 25 g/day × 7, then 5 g/day | Powers 2003 (32) |
| Week 6 | Fatigue resistance +7–11%; no change in body mass or strength | ~2.3 g/day | Rawson 2011 (20) |
| Week 8 | Lean tissue and bench-press gains over placebo, with training | weight-scaled loading, then maintenance | Burke 2003 (42) |
Read down the "what moved" column and a sequence appears: the muscle fills first, water-linked mass follows, repeated-effort performance comes next, and strength and lean tissue show up only in trials long enough to include a training programme. Only one study in this set reports a one-repetition-maximum gain inside the first week, and only in its three strongest responders (Syrotuik 2004, below). The day-5 finding in Greenhaff 1993 is about sustaining torque across repeated bouts, which is what extra phosphocreatine predicts.
Stage one: filling the muscle
The founding numbers come from biopsies of the quadriceps. Harris and colleagues found uptake was greatest over the first two days of 5 g doses taken four or six times a day, accounting for 32% of the dose in three subjects, with the rest increasingly excreted (Harris 1992, PMID 1327657). Hultman's group then ran both routes in 31 men: about 20% after six days at 20 g a day, and "a similar, but more gradual, 20% increase" over 28 days at 3 g a day (Hultman 1996, PMID 8828669).
So the answer to "how long until the muscle is full" is a choice between two clocks — about a week or about a month — arriving at the same place. The full provenance of the loading protocol, including the fact that neither founding study measured strength, is on the creatine loading phase. How the daily figures on labels trace back to these papers is on how much creatine the studies used.
Stage two: the scale
The weight change is the first thing most people notice, and it is mostly water drawn into muscle with the creatine. Powers and colleagues measured it with isotope dilution rather than guessing: in 32 resistance-trained men and women, body mass was 0.75 kg higher at day 7 after 25 g a day — short of the 0.88 kg their statistics needed to call it significant — and significantly higher by day 28, alongside a rise in total body water (Powers 2003, PMID 12937471). The water stayed in the same proportions inside and outside cells. What the scale is and is not showing is covered on does creatine make you gain weight.
The low-intake route can skip this stage. Rawson's six-week trial at about 2.3 g a day recorded no change in body mass, fat-free mass or total body water — and still measured a performance effect (Rawson 2011, PMID 20591625). The scale is therefore a poor signal of whether creatine is doing anything.
Stage three: repeated hard efforts
This is what the phosphocreatine system is for, and it is where the earliest randomised effect sits. In Greenhaff 1993, twelve subjects did five bouts of 30 maximal isokinetic contractions before and after five days of creatine or glucose. After creatine, peak torque was higher in all six creatine subjects in the later contractions of bout 1 and through bouts 2 and 3; nothing changed on placebo (Greenhaff 1993, PMID 8504634).
Rawson's low-intake trial reached a comparable place by week six: resistance to fatigue improved by 7%, 9%, 9% and 11% across sets 2 to 5 of repeated knee extensions, with no change on placebo — and maximal strength did not change (Rawson 2011). The pattern across both is the same: creatine first shows up as the ability to repeat a hard effort, not as a bigger single effort.
Stage four: strength and muscle
Gains in one-repetition maximum and lean tissue appear in trials that pair creatine with weeks of training, because the proposed route is more work done per session. Burke and colleagues ran eight weeks of resistance training in 42 vegetarians and non-vegetarians and found larger increases in bench-press strength, type II fibre area and whole-body lean tissue on creatine than on placebo (Burke 2003, PMID 14600563). What the wider evidence grades as established, and what it does not, is set out endpoint by endpoint on creatine benefits.
The honest reading is that "how long for strength" is really "how long for enough training": the trials are measured in weeks to months, and no trial isolates the week at which a strength difference first appears.
Why some people wait and nothing happens
Greenhaff's 1994 biopsy study found a split that later work kept reproducing. After five days at 20 g a day, five of eight subjects raised muscle total creatine by 15–32%; the other three rose by only 5–7%, and their phosphocreatine resynthesis did not improve at all (Greenhaff 1994, PMID 8203511). Powers 2003 counted 4 of its creatine group (28%) as non-responders, citing Greenhaff's estimate that 20–30% of people fall below a 10 mmol/kg rise.
Syrotuik and Bell described who they tend to be. In 11 men given a five-day load, the three clear responders started with the lowest muscle creatine, the most type II fibres and the most fat-free mass; the three non-responders started highest, had fewer type II fibres, and showed no change in 1RM (Syrotuik 2004, PMID 15320650). The mirror image is the group that starts lowest of all: people who eat no meat, whose larger measured response is covered on creatine for vegetarians and vegans.
Where the "one to two weeks" answer comes from
Search results for this question are dominated by supplement sellers, and the "one to two weeks" figure they repeat usually arrives without a citation. The biopsy literature supports a narrower claim: stores near their plateau within a week on a loading intake, or about a month without one. It does not support a noticeable strength or muscle gain within one to two weeks for most people, and it says clearly that roughly a fifth to a third of subjects in the small biopsy studies barely filled at all.
For context on standing: the Australian Institute of Sport places creatine monohydrate in Group A of its sports supplement framework, its strongest-evidence tier for use in specific sporting situations (AIS supplement framework, Group A). Timing within the day is a separate question, answered on creatine timing.
What is not established
- No trial measured the day a strength difference first appears. The strength data come from end-of-programme tests.
- The biopsy studies are small and mostly male. Hultman 1996 enrolled 31 men; Greenhaff 1994, eight people; Syrotuik 2004, eleven men.
- Responder status cannot be predicted outside a lab. The markers that separate responders — baseline muscle creatine, fibre type — need a biopsy.
- "Working" was never defined the same way twice. Each trial chose its own endpoint, which is why the timeline above has to name one per row.
Sources and dates
- Harris RC, Söderlund K, Hultman E. Elevation of creatine in resting and exercised muscle of normal subjects by creatine supplementation. Clin Sci 1992;83:367–74 — PMID 1327657
- Greenhaff PL, Casey A, Short AH, et al. Influence of oral creatine supplementation of muscle torque during repeated bouts of maximal voluntary exercise in man. Clin Sci 1993;84:565–71 — PMID 8504634
- Greenhaff PL, Bodin K, Söderlund K, Hultman E. Effect of oral creatine supplementation on skeletal muscle phosphocreatine resynthesis. Am J Physiol 1994;266:E725–30 — PMID 8203511
- Hultman E, Söderlund K, Timmons JA, et al. Muscle creatine loading in men. J Appl Physiol 1996;81:232–7 — PMID 8828669
- Powers ME, Arnold BL, Weltman AL, et al. Creatine supplementation increases total body water without altering fluid distribution. J Athl Train 2003;38:44–50 — PMID 12937471
- Burke DG, Chilibeck PD, Parise G, et al. Effect of creatine and weight training on muscle creatine and performance in vegetarians. Med Sci Sports Exerc 2003;35:1946–55 — PMID 14600563
- Syrotuik DG, Bell GJ. Acute creatine monohydrate supplementation: a descriptive physiological profile of responders vs. nonresponders. J Strength Cond Res 2004;18:610–7 — PMID 15320650
- Rawson ES, Stec MJ, Frederickson SJ, Miles MP. Low-dose creatine supplementation enhances fatigue resistance in the absence of weight gain. Nutrition 2011;27:451–5 — PMID 20591625
- Australian Institute of Sport, Sports Supplement Framework — Group A, read 2026-09-23.